https://elliogen.com 2026-09-05T11:32:08.894Z weekly 1 https://elliogen.com/about 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/services 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/services/french-market-access 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/services/exploitant-support-france 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/services/patient-mapping-france 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/services/pharma-launch-planning-france 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/resources 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/exploitant-in-france-complete-guide 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/exploitant 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/case-study-us-biotech-france 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/cost-calculator 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/mapping 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/blog 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/contact 2026-09-05T11:32:08.894Z weekly 0.8 https://elliogen.com/blog/what-is-an-exploitant 2026-08-24T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/launching-a-pharmaceutical-product-in-france-a-practical-step-by-step-roadmap-for-international-companies 2025-12-12T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/how-patient-engagement-is-transforming-market-access 2025-11-12T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/how-much-does-it-really-cost-to-launch-a-pharma-product-in-france 2025-09-09T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/launch-planning-in-pharma-why-patient-and-stakeholder-mapping-matters-more-than-ever 2025-08-27T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/understanding-the-ns-mention-in-france-what-pharmaceutical-companies-need-to-know 2025-08-01T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/faq-the-role-of-the-exploitant-in-the-pharmaceutical-industry 2025-07-16T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/understanding-the-reimbursement-process-for-prescription-medicines-in-france 2025-07-09T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/how-to-choose-the-right-exploitant-in-france-a-practical-guide 2025-07-08T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/how-to-bring-your-drug-to-french-patients-before-approval-compassionate-use-acces-precoce-explained 2025-07-07T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/your-2026-guide-to-pharma-market-access-in-france 2025-07-04T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/white-paper-navigating-the-french-pharmaceutical-market 2025-06-24T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/top-5-mistakes-pharma-companies-make-when-entering-france-and-how-to-avoid-them 2025-04-14T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/understanding-the-pharmaceutical-distribution-system-in-france 2025-04-14T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/the-untapped-power-of-digital-revolutionizing-patient-engagement-in-pharma 2025-03-12T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/parallel-import-opportunities-in-the-eu-pharmaceutical-market-a-complete-guide 2025-02-12T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/contract-research-organizations-cros-in-france 2025-01-17T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/launching-a-pharma-product-in-europe-a-country-by-country-guide-for-pharmaceutical-companies 2024-11-27T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/mastering-brand-positioning-in-prescription-only-medicine 2024-10-17T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/unlocking-the-french-pharmaceutical-market-how-u-s-pharma-companies-can-benefit-from-a-local-exploitant 2024-04-15T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/pathways-to-approval-navigating-eu-pharmaceutical-regulation-through-cp-and-dcp 2024-02-21T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/launching-an-early-access-program-in-france-a-guide-for-pharmaceutical-companies 2024-01-30T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/understanding-prescription-dynamics-in-france-branded-vs-generic-medication 2024-01-29T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/navigating-the-french-healthcare-reimbursement-system-a-guide-for-pharmaceutical-companies 2024-01-29T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/oncology-in-france-opportunities-for-pharma-companies-and-cros 2024-01-25T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/navigating-the-world-of-expanded-access-programs-eap-in-pharma-and-biotech 2024-01-24T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/understanding-exploitant-status-vs-establishing-your-regulatory-office 2024-01-23T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/understanding-service-medical-rendu-in-the-french-healthcare-system 2024-01-19T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/navigating-the-french-healthcare-system-understanding-government-bodies-and-their-roles 2024-01-18T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/the-early-access-program-in-france 2023-11-29T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/centralised-procedure-in-europe-a-primer-for-us-based-pharmaceutical-companies 2023-08-22T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/infographic-french-pharmaceutical-market 2022-07-27T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/investing-in-off-patent-products 2022-06-23T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/what-affects-the-supply-of-medicine-in-the-pharmaceutical-industry 2021-02-20T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/patient-journey-why-bother-2 2021-02-06T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/french-retail-pharmacies 2021-02-04T00:00:00.000Z monthly 0.7 https://elliogen.com/blog/pharma-on-social-media 2021-02-02T00:00:00.000Z monthly 0.7